Compared with the original ARDS cohort, patients with ARDS in 2015 have very different-and diversefindings at autopsy. In a recent article in Intensive Care Medicine, Lorente and colleagues question the definition of ARDS [5] . They reviewed the records of patients who died and had an autopsy, but who, while alive, fulfilled criteria for ARDS; and, they compared the clinical features of those who had diffuse alveolar damage (DAD, the histologic hallmark of ventilation-associated injury) versus those who did not. The presence of DAD on autopsy was associated with greater severity of ARDS. While this finding questions the role of a histologic 'gold standard' for diagnosis of ARDS, perhaps the first question is: 'Is there a gold standard for ARDS'? Let us step away from ARDS and consider a diagnostic test for cancer against a histologic 'gold standard': a test with high sensitivity would miss few 'true' cancers but might include many non-cancers; in contrast, a good 'diagnostic' test would yield few false positives. To apply this reasoning in ARDS, the first step is to determine if there is a gold standard. Many believe that the gold standard for ARDS is 'DAD' [6, 7] , and, if true, then the Berlin definition performs well as a screening test (i.e. misses few cases), but it over-diagnoses the condition (i.e. includes many who do not have positive histology).
Using limited autopsy data, Lorente et al. refer to a reference standard [5] ; however, at the time of their inception, neither the AECC nor Berlin criteria for ARDS were validated against clinical data (i.e., a range of patients who might or might not have the condition, subsequently adjudicated against another method) [8] . Without a reference standard, a 'validated' diagnosis in research often consists of two clinicians' agreement on a chest X-ray (which is often poor) [9] . In clinical practice, of course, the diagnosis may be based on the judgment of a single clinician.
There are important reasons why a definition of ARDS may be useful and necessary. We believe that a definition Intensive Care Med (2016) 42:284-286 DOI 10.1007/s00134-015-4150-1 of ARDS is useful for population comparisons or planning. Such information is relatively basic and concerns severity of illness and major needs for care. For example, a minimal number of variables from a large database of ICU patients could reliably identify those who developed acute respiratory failure, or hypoxemia, or who required mechanical ventilation for several days. Capturing such patients is key to planning for resources and staffing and for comparing outcomes across regions or countries. Sometimes, more specific details may not matter so much. If the purpose is to know how many patients will need an ICU bed or a mechanical ventilator, then almost any definition of ARDS would perform well.
In some settings, especially where personalized medicine is not embraced (or where expertise is limited), a definition of 'ARDS' may serve as a means of entry to a standardized treatment plan, e.g., a protocol for ARDS. In such situations, the emphasis is on the 'syndrome' as opposed to the individual patient's diagnosis, and the provision of the care will reflect a more approximate sense of the patient's condition. Nonetheless, a simplistic definition of ARDS might elevate previously low standards of care.
A major use for a definition is to determine entry into a clinical study. In some cases, an approximate definition may suffice. An extreme example might be a study testing the effectiveness of hand washing, because here the biologic characteristics of the lung disease might not matter much. In contrast, to test the effectiveness of lung recruitment one would wish to include only patients with (and, equally, exclude those without) recruitable lung. Thus, in order to be useful as a sole entry criterion, a definition of ARDS would need to incorporate the physiologic (or molecular) mechanisms under investigation.
This illustrates a major problem with clinical studies in ARDS. If histology is the gold standard for ARDS, then using the consensus definitions (AECC, Berlin) for recruiting patients into RCTs means that about 50 % of those recruited probably did not have ARDS [10] . Also, even if the RCTs included only patients with ('true') ARDS, interpretation is confounded because ARDS is a syndrome (not a disease) with multiple causes and outcomes. Thus, clinical studies contain substantial 'noise', reflecting biological complexity and reducing statistical power. Indeed, many 'negative' RCT answers may be indeterminate [11] .
Syndromes are also a problem. We see many critically ill patients with 'encephalopathy'; such a label prompts a search among multiple possible explanations (e.g., thrombosis, hemorrhage, demyelination, infection, metabolic processes), each of which has a different cause, treatment and outcome. 'Encephalopathy' is never a singular diagnosis, or an indicator for a singular therapy; instead, the label signals the need for assessment and diagnosis. We cannot imagine, in the acutely injured lung, any combination of hypoxemia, PEEP and pulmonary infiltrates that would reliably predict a singular histologic appearance. However, we believe that fulfilling (any of) the consensus definitions should alert the clinician to search for a cause, and if mechanical ventilation is needed, to be aware of the dangers of ventilator-associated injury. This seems to be wise if the condition is ultimately classified as 'ARDS', or as a mimic of ARDS.
In the end, treating the patient is what matters. Any definition that directly assists patient management, or increases the yield of interpretable research, will have some use. However, we hope that future definitions of 'ARDS' will take into account the physiological and biochemical mechanisms at play; this, of course, is no simple matter. Conflicts of interest None of the authors have a financial conflict of interest in the subject matter of this article.
